메뉴 건너뛰기




Volumn 34, Issue 1, 2015, Pages

Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients

Author keywords

Breast cancer; Immunohistochemistry; MUC1; PankoMab GEX ; Prognosis; TA MUC1

Indexed keywords

BIOLOGICAL MARKER; EPITOPE; MONOCLONAL ANTIBODY; MUCIN 1; PANKOMAB GEX; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; PANKOMAB-GEX; TUMOR ANTIGEN; TUMOR MARKER;

EID: 84930226290     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/s13046-015-0152-7     Document Type: Article
Times cited : (14)

References (33)
  • 1
    • 36849069347 scopus 로고    scopus 로고
    • American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
    • 1:CAS:528:DC%2BD2sXhsVKnsbzK 17954709
    • Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, et al. American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25(33):5287-312.
    • (2007) J Clin Oncol , vol.25 , Issue.33 , pp. 5287-5312
    • Harris, L.1    Fritsche, H.2    Mennel, R.3    Norton, L.4    Ravdin, P.5    Taube, S.6
  • 2
    • 0030680989 scopus 로고    scopus 로고
    • Mucins (MUC1 and MUC3) of gastrointestinal and breast epithelia reveal different and heterogeneous tumor-associated aberrations in glycosylation
    • 1:CAS:528:DyaK2sXntVSqt7g%3D 9358856
    • Cao Y, Blohm D, Ghadimi BM, Stosiek P, Xing PX, Karsten U. Mucins (MUC1 and MUC3) of gastrointestinal and breast epithelia reveal different and heterogeneous tumor-associated aberrations in glycosylation. J Histochem Cytochem. 1997;45(11):1547-57.
    • (1997) J Histochem Cytochem , vol.45 , Issue.11 , pp. 1547-1557
    • Cao, Y.1    Blohm, D.2    Ghadimi, B.M.3    Stosiek, P.4    Xing, P.X.5    Karsten, U.6
  • 3
    • 4444313524 scopus 로고    scopus 로고
    • Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1)
    • 1:CAS:528:DC%2BD2cXltlyjsrY%3D 15115750
    • Karsten U, Serttas N, Paulsen H, Danielczyk A, Goletz S. Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1). Glycobiology. 2004;14(8):681-92.
    • (2004) Glycobiology , vol.14 , Issue.8 , pp. 681-692
    • Karsten, U.1    Serttas, N.2    Paulsen, H.3    Danielczyk, A.4    Goletz, S.5
  • 4
    • 84873844780 scopus 로고    scopus 로고
    • Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8
    • 23275306
    • Dian D, Lenhard M, Mayr D, Heublein S, Karsten U, Goletz S, et al. Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8. Histol Histopathol. 2013;28(2):239-44.
    • (2013) Histol Histopathol , vol.28 , Issue.2 , pp. 239-244
    • Dian, D.1    Lenhard, M.2    Mayr, D.3    Heublein, S.4    Karsten, U.5    Goletz, S.6
  • 5
    • 84868374858 scopus 로고    scopus 로고
    • Distinct cytoplasmic expression of KL-6 mucin in chromophobe renal cell carcinoma: A comparative immunohistochemical study with other renal epithelial cell tumors
    • 3496866 1:CAS:528:DC%2BC38XhslajurbP 23209339
    • Fukushima M, Higuchi K, Shimojo H, Uehara T, Ota H. Distinct cytoplasmic expression of KL-6 mucin in chromophobe renal cell carcinoma: a comparative immunohistochemical study with other renal epithelial cell tumors. Acta Histochemica et Cytochemica. 2012;45(5):301-8.
    • (2012) Acta Histochemica et Cytochemica , vol.45 , Issue.5 , pp. 301-308
    • Fukushima, M.1    Higuchi, K.2    Shimojo, H.3    Uehara, T.4    Ota, H.5
  • 7
    • 24644440098 scopus 로고    scopus 로고
    • What makes MUC1 a tumor antigen?
    • 1:CAS:528:DC%2BD2MXpvVSmsbk%3D 16006776
    • Karsten U, von Mensdorff-Pouilly S, Goletz S. What makes MUC1 a tumor antigen? Tumour Biol. 2005;26(4):217-20.
    • (2005) Tumour Biol , vol.26 , Issue.4 , pp. 217-220
    • Karsten, U.1    Von Mensdorff-Pouilly, S.2    Goletz, S.3
  • 8
    • 0032526177 scopus 로고    scopus 로고
    • Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation
    • 1:CAS:528:DyaK1cXktVajt7Y%3D 9635576
    • Karsten U, Diotel C, Klich G, Paulsen H, Goletz S, Muller S, et al. Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation. Cancer Res. 1998;58(12):2541-9.
    • (1998) Cancer Res , vol.58 , Issue.12 , pp. 2541-2549
    • Karsten, U.1    Diotel, C.2    Klich, G.3    Paulsen, H.4    Goletz, S.5    Muller, S.6
  • 10
    • 77954349368 scopus 로고    scopus 로고
    • Reactivity of a humanized antibody (hPankoMab) towards a tumor-related MUC1 epitope (TA-MUC1) with various human carcinomas
    • 1:CAS:528:DC%2BC3cXpsVGntrk%3D 20400237
    • Fan XN, Karsten U, Goletz S, Cao Y. Reactivity of a humanized antibody (hPankoMab) towards a tumor-related MUC1 epitope (TA-MUC1) with various human carcinomas. Pathol Res Pract. 2010;206(8):585-9.
    • (2010) Pathol Res Pract , vol.206 , Issue.8 , pp. 585-589
    • Fan, X.N.1    Karsten, U.2    Goletz, S.3    Cao, Y.4
  • 11
    • 67549118583 scopus 로고    scopus 로고
    • Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; Comparison with two established antibodies
    • 1:CAS:528:DC%2BD1MXlslGhur4%3D 19420969
    • Dian D, Janni W, Kuhn C, Mayr D, Karsten U, Mylonas I, et al. Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies. Onkologie. 2009;32(5):238-44.
    • (2009) Onkologie , vol.32 , Issue.5 , pp. 238-244
    • Dian, D.1    Janni, W.2    Kuhn, C.3    Mayr, D.4    Karsten, U.5    Mylonas, I.6
  • 12
    • 84880940822 scopus 로고    scopus 로고
    • Multicentric and multifocal versus unifocal breast cancer: Differences in the expression of E-cadherin suggest differences in tumor biology
    • 3729674 1:CAS:528:DC%2BC3sXht1Ontb3N 23890049
    • Weissenbacher T, Hirte E, Kuhn C, Janni W, Mayr D, Karsten U, et al. Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology. BMC Cancer. 2013;13:361.
    • (2013) BMC Cancer , vol.13 , pp. 361
    • Weissenbacher, T.1    Hirte, E.2    Kuhn, C.3    Janni, W.4    Mayr, D.5    Karsten, U.6
  • 13
    • 84861498499 scopus 로고    scopus 로고
    • Determination of MUC1 in sera of ovarian cancer patients and in sera of patients with benign changes of the ovaries with CA15-3, CA27.29, and PankoMab
    • 1:CAS:528:DC%2BC38XovVWgsbs%3D 22593508
    • Jeschke U, Wiest I, Schumacher AL, Kupka M, Rack B, Stahn R, et al. Determination of MUC1 in sera of ovarian cancer patients and in sera of patients with benign changes of the ovaries with CA15-3, CA27.29, and PankoMab. Anticancer Res. 2012;32(5):2185-9.
    • (2012) Anticancer Res , vol.32 , Issue.5 , pp. 2185-2189
    • Jeschke, U.1    Wiest, I.2    Schumacher, A.L.3    Kupka, M.4    Rack, B.5    Stahn, R.6
  • 14
    • 0027404657 scopus 로고
    • Method for grading breast cancer
    • 501162 1:STN:280:DyaK3s3htVaitQ%3D%3D 8459046
    • Elston EW, Ellis IO. Method for grading breast cancer. J Clin Pathol. 1993;46(2):189-90.
    • (1993) J Clin Pathol , vol.46 , Issue.2 , pp. 189-190
    • Elston, E.W.1    Ellis, I.O.2
  • 15
    • 23844534811 scopus 로고    scopus 로고
    • Reporting recommendations for tumor marker prognostic studies (REMARK)
    • 1:CAS:528:DC%2BD2MXpsVaks7s%3D 16106022
    • McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst. 2005;97(16):1180-4.
    • (2005) J Natl Cancer Inst , vol.97 , Issue.16 , pp. 1180-1184
    • McShane, L.M.1    Altman, D.G.2    Sauerbrei, W.3    Taube, S.E.4    Gion, M.5    Clark, G.M.6
  • 16
    • 63449121342 scopus 로고    scopus 로고
    • Immunohistochemical expression of glycodelin in breast cancer correlates with estrogen-receptor alpha and progesterone-receptor A positivity
    • 1:CAS:528:DC%2BD1MXltFCntr8%3D 19224449
    • Scholz C, Toth B, Barthell E, Mylonas I, Weissenbacher T, Friese K, et al. Immunohistochemical expression of glycodelin in breast cancer correlates with estrogen-receptor alpha and progesterone-receptor A positivity. Histol Histopathol. 2009;24(4):467-71.
    • (2009) Histol Histopathol , vol.24 , Issue.4 , pp. 467-471
    • Scholz, C.1    Toth, B.2    Barthell, E.3    Mylonas, I.4    Weissenbacher, T.5    Friese, K.6
  • 17
    • 84869877511 scopus 로고    scopus 로고
    • Steroid hormone receptor expression in ovarian cancer: Progesterone receptor B as prognostic marker for patient survival
    • 3575289 1:CAS:528:DC%2BC3sXjs12mt7o%3D 23176303
    • Lenhard M, Tereza L, Heublein S, Ditsch N, Himsl I, Mayr D, et al. Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival. BMC Cancer. 2012;12(1):553.
    • (2012) BMC Cancer , vol.12 , Issue.1 , pp. 553
    • Lenhard, M.1    Tereza, L.2    Heublein, S.3    Ditsch, N.4    Himsl, I.5    Mayr, D.6
  • 18
    • 84855253240 scopus 로고    scopus 로고
    • Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
    • 3311592 1:CAS:528:DC%2BC38Xlsl2rsL0%3D 22214378
    • Lenhard M, Tsvilina A, Schumacher L, Kupka M, Ditsch N, Mayr D, et al. Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer. BMC Cancer. 2012;12:2.
    • (2012) BMC Cancer , vol.12 , pp. 2
    • Lenhard, M.1    Tsvilina, A.2    Schumacher, L.3    Kupka, M.4    Ditsch, N.5    Mayr, D.6
  • 19
    • 34548550761 scopus 로고    scopus 로고
    • Subcellular localization of KL-6 mucin in colorectal carcinoma cell lines: Association with metastatic potential and cell morphology
    • 1:CAS:528:DC%2BD2sXlsVynu7g%3D 17390044
    • Guo Q, Tang W, Inagaki Y, Kokudo N, Sugawara Y, Karako H, et al. Subcellular localization of KL-6 mucin in colorectal carcinoma cell lines: association with metastatic potential and cell morphology. Oncol Rep. 2007;17(5):1057-60.
    • (2007) Oncol Rep , vol.17 , Issue.5 , pp. 1057-1060
    • Guo, Q.1    Tang, W.2    Inagaki, Y.3    Kokudo, N.4    Sugawara, Y.5    Karako, H.6
  • 20
    • 31144441419 scopus 로고    scopus 로고
    • Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues
    • 4077483 1:CAS:528:DC%2BD28XhslWrs70%3D 16440417
    • Guo Q, Tang W, Inagaki Y, Midorikawa Y, Kokudo N, Sugawara Y, et al. Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues. World J Gastroenterol. 2006;12(1):54-9.
    • (2006) World J Gastroenterol , vol.12 , Issue.1 , pp. 54-59
    • Guo, Q.1    Tang, W.2    Inagaki, Y.3    Midorikawa, Y.4    Kokudo, N.5    Sugawara, Y.6
  • 21
    • 0034969487 scopus 로고    scopus 로고
    • EMA: A differentiation antigen related to node metastatic capacity of breast carcinomas
    • 1:STN:280:DC%2BD38%2Fhslarsg%3D%3D 11432669
    • Luna-More S, Rius F, Weil B, Jimenez A, Bautista MD, Perez-Mellado A. EMA: a differentiation antigen related to node metastatic capacity of breast carcinomas. Pathol Res Pract. 2001;197(6):419-25.
    • (2001) Pathol Res Pract , vol.197 , Issue.6 , pp. 419-425
    • Luna-More, S.1    Rius, F.2    Weil, B.3    Jimenez, A.4    Bautista, M.D.5    Perez-Mellado, A.6
  • 22
    • 34447517882 scopus 로고    scopus 로고
    • The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma
    • 17645748
    • van der Vegt B, de Roos MA, Peterse JL, Patriarca C, Hilkens J, de Bock GH, et al. The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma. Histopathology. 2007;51(3):322-35.
    • (2007) Histopathology , vol.51 , Issue.3 , pp. 322-335
    • Van Der Vegt, B.1    De Roos, M.A.2    Peterse, J.L.3    Patriarca, C.4    Hilkens, J.5    De Bock, G.H.6
  • 23
    • 30744474431 scopus 로고    scopus 로고
    • MUC1 oncoprotein stabilizes and activates estrogen receptor alpha
    • 1:CAS:528:DC%2BD28Xht12rsLo%3D 16427018
    • Wei X, Xu H, Kufe D. MUC1 oncoprotein stabilizes and activates estrogen receptor alpha. Mol Cell. 2006;21(2):295-305.
    • (2006) Mol Cell , vol.21 , Issue.2 , pp. 295-305
    • Wei, X.1    Xu, H.2    Kufe, D.3
  • 24
    • 80455144484 scopus 로고    scopus 로고
    • Randomized phase II trial of letrozole plus anti-MUC1 antibody AS1402 in hormone receptor-positive locally advanced or metastatic breast cancer
    • 1:CAS:528:DC%2BC3MXhsVWlsr%2FF 21878535
    • Ibrahim NK, Yariz KO, Bondarenko I, Manikhas A, Semiglazov V, Alyasova A, et al. Randomized phase II trial of letrozole plus anti-MUC1 antibody AS1402 in hormone receptor-positive locally advanced or metastatic breast cancer. Clin Cancer Res. 2011;17(21):6822-30.
    • (2011) Clin Cancer Res , vol.17 , Issue.21 , pp. 6822-6830
    • Ibrahim, N.K.1    Yariz, K.O.2    Bondarenko, I.3    Manikhas, A.4    Semiglazov, V.5    Alyasova, A.6
  • 25
    • 84898764219 scopus 로고    scopus 로고
    • HER2 in breast cancer: A review and update
    • 1:CAS:528:DC%2BC2cXisVCjtbk%3D 24508693
    • Krishnamurti U, Silverman JF. HER2 in breast cancer: a review and update. Adv Anat Pathol. 2014;21(2):100-7.
    • (2014) Adv Anat Pathol , vol.21 , Issue.2 , pp. 100-107
    • Krishnamurti, U.1    Silverman, J.F.2
  • 26
    • 84904984976 scopus 로고    scopus 로고
    • C-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer
    • 1:CAS:528:DC%2BC3sXhsVyqu7zP 24056965
    • Nair R, Roden DL, Teo WS, McFarland A, Junankar S, Ye S, et al. c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer. Oncogene. 2014;33(30):3992-4002.
    • (2014) Oncogene , vol.33 , Issue.30 , pp. 3992-4002
    • Nair, R.1    Roden, D.L.2    Teo, W.S.3    McFarland, A.4    Junankar, S.5    Ye, S.6
  • 27
    • 84903560408 scopus 로고    scopus 로고
    • AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: Preclinical activity in HER2 non-amplified inflammatory breast cancer models
    • 4061513 24886365
    • Mu Z, Klinowska T, Dong X, Foster E, Womack C, Fernandez SV, et al. AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models. J Exp Clin Cancer Res. 2014;33:47.
    • (2014) J Exp Clin Cancer Res , vol.33 , pp. 47
    • Mu, Z.1    Klinowska, T.2    Dong, X.3    Foster, E.4    Womack, C.5    Fernandez, S.V.6
  • 28
    • 71849093863 scopus 로고    scopus 로고
    • MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features
    • 18948041
    • de Oliveira JT, Pinho SS, de Matos AJ, Hespanhol V, Reis CA, Gartner F. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features. Vet J. 2009;182(3):491-3.
    • (2009) Vet J , vol.182 , Issue.3 , pp. 491-493
    • De Oliveira, J.T.1    Pinho, S.S.2    De Matos, A.J.3    Hespanhol, V.4    Reis, C.A.5    Gartner, F.6
  • 29
    • 84865060283 scopus 로고    scopus 로고
    • MUC1c regulates cell survival in pancreatic cancer by preventing lysosomal permeabilization
    • 3418232 1:CAS:528:DC%2BC38Xht1amsr%2FM 22912777
    • Banerjee S, Mujumdar N, Dudeja V, Mackenzie T, Krosch TK, Sangwan V, et al. MUC1c regulates cell survival in pancreatic cancer by preventing lysosomal permeabilization. PLoS One. 2012;7(8):e43020.
    • (2012) PLoS One , vol.7 , Issue.8 , pp. 43020
    • Banerjee, S.1    Mujumdar, N.2    Dudeja, V.3    Mackenzie, T.4    Krosch, T.K.5    Sangwan, V.6
  • 30
    • 84878554709 scopus 로고    scopus 로고
    • Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer
    • 3670483 1:CAS:528:DC%2BC3sXosFKlt78%3D 23652307
    • Burford B, Gentry-Maharaj A, Graham R, Allen D, Pedersen JW, Nudelman AS, et al. Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer. Br J Cancer. 2013;108(10):2045-55.
    • (2013) Br J Cancer , vol.108 , Issue.10 , pp. 2045-2055
    • Burford, B.1    Gentry-Maharaj, A.2    Graham, R.3    Allen, D.4    Pedersen, J.W.5    Nudelman, A.S.6
  • 32
    • 79959339930 scopus 로고    scopus 로고
    • Breast cancer humoral immune response: Involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1)
    • 19715603
    • Isla Larrain M, Demichelis S, Crespo M, Lacunza E, Barbera A, Creton A, et al. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1). J Exp Clin Cancer Res. 2009;28:121.
    • (2009) J Exp Clin Cancer Res , vol.28 , pp. 121
    • Isla Larrain, M.1    Demichelis, S.2    Crespo, M.3    Lacunza, E.4    Barbera, A.5    Creton, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.